Marine Bromophenol Bis (2,3-Dibromo-4,5-dihydroxy-phenyl)-methane Inhibits the Proliferation, Migration, and Invasion of Hepatocellular Carcinoma Cells via Modulating β1-Integrin/FAK Signaling

Cordycepin Suppresses Integrin/FAK Signaling and Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma

(2014) Wen-Ling Yao et al.   Anti-Cancer Agents in Medicinal Chemistry

Androgen receptor enhances cell adhesion and decreases cell migration via modulating β1-integrin-AKT signaling in hepatocellular carcinoma cells

(2014) Wen-Lung Ma et al.   CANCER LETTERS

Editorial overview: Cell adhesion and migration

(2014) Anna Huttenlocher et al.   CURRENT OPINION IN CELL BIOLOGY

Bis(2,3-dibromo-4,5-dihydroxybenzyl) Ether, a Marine Algae Derived Bromophenol, Inhibits the Growth of Botrytis cinerea and Interacts with DNA Molecules

(2014) Ming Liu et al.   Marine Drugs

Genome-Wide Screening Identified That miR-134 Acts as a Metastasis Suppressor by Targeting Integrin β1 in Hepatocellular Carcinoma

(2014) Ruopeng Zha et al.   PLoS One

Knockdown and knockout of β1-integrin in hepatocytes impairs liver regeneration through inhibition of growth factor signalling

(2014) Tobias Speicher et al.   Nature Communications

A novel protein from Eupolyphaga sinensis inhibits adhesion, migration, and invasion of human lung cancer A549 cells

(2013) Feng-xia Wang et al.   Biochemistry and Cell Biology

MiR-125b acts as an oncogene in glioblastoma cells and inhibits cell apoptosis through p53 and p38MAPK-independent pathways

(2013) N Wu et al.   BRITISH JOURNAL OF CANCER

Halogenated Organic Molecules of Rhodomelaceae Origin: Chemistry and Biology

(2013) Bin-Gui Wang et al.   CHEMICAL REVIEWS

Phase Ib safety and pharmacokinetic study of volociximab, an anti-α5β1 integrin antibody, in combination with carboplatin and paclitaxel in advanced non-small-cell lung cancer

(2012) B. Besse et al.   ANNALS OF ONCOLOGY

Farnesoid X Receptor Protects Hepatocytes From Injury by Repressing miR-199a-3p, Which Increases Levels of LKB1

(2012) Chan Gyu Lee et al.   GASTROENTEROLOGY

Randomized phase II study of three doses of the integrin inhibitor cilengitide versus docetaxel as second-line treatment for patients with advanced non-small-cell lung cancer

(2012) Christian Manegold et al.   INVESTIGATIONAL NEW DRUGS

β1 Integrin/FAK/cortactin signaling is essential for human head and neck cancer resistance to radiotherapy

(2012) Iris Eke et al.   JOURNAL OF CLINICAL INVESTIGATION

Indole-Derived Psammaplin A Analogues as Epigenetic Modulators with Multiple Inhibitory Activities

(2012) Raquel Pereira et al.   JOURNAL OF MEDICINAL CHEMISTRY

A randomized phase II study of cilengitide (EMD 121974) in patients with metastatic melanoma

(2012) Kevin B. Kim et al.   MELANOMA RESEARCH

Marine bromophenol bis(2,3-dibromo-4,5-dihydroxybenzyl) ether, induces mitochondrial apoptosis in K562 cells and inhibits topoisomerase I in vitro

(2012) Ming Liu et al.   TOXICOLOGY LETTERS

Promyogenic function of Integrin/FAK signaling is mediated by Cdo, Cdc42 and MyoD

(2011) Ji-Won Han et al.   CELLULAR SIGNALLING

Synthesis and α-Glucosidase Inhibitory Mechanisms of Bis(2,3-dibromo-4,5-dihydroxybenzyl) Ether, a Potential Marine Bromophenol α-Glucosidase Inhibitor

(2011) Ming Liu et al.   Marine Drugs

The antitumor effect of bromophenol derivatives in vitro and Leathesia nana extract in vivo

(2009) Dayong Shi et al.   CHINESE JOURNAL OF OCEANOLOGY AND LIMNOLOGY

β1 integrin/FAK/ERK signalling pathway is essential for human fetal islet cell differentiation and survival

(2009) Saira Saleem et al.   JOURNAL OF PATHOLOGY

β1 integrin/Fak/Src signaling in intestinal epithelial crypt cell survival: integration of complex regulatory mechanisms

(2008) Véronique Bouchard et al.   APOPTOSIS

Synthesis and antimicrobial activities of halogenated bis(hydroxyphenyl)methanes

(2008) Ki-Bong Oh et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Total synthesis of bis-(2,3-dibromo-4,5-dihydroxyphenyl)-methane as potent PTP1B inhibitor

(2008) Jing Li et al.   CHINESE CHEMICAL LETTERS

Randomized Phase II Study of Cilengitide, an Integrin-Targeting Arginine-Glycine-Aspartic Acid Peptide, in Recurrent Glioblastoma Multiforme

(2008) David A. Reardon et al.   JOURNAL OF CLINICAL ONCOLOGY